Market Overview The acquired autoimmune hemolytic anemia (AIHA) market is growing due to the increasing prevalence of autoimmune disorders, rising awareness of rare hematological diseases, and advancements in targeted therapies. AIHA is a condition where the immune system mistakenly destroys red blood cells, leading to anemia, fatigue, and organ damage. Treatment options, including...